08.04.2016 • NewsDede WillamsSyngentaMonsanto

Monsanto No Longer After Large-Scale Deals

Getting back to business after the collapse of the plan to take over Swiss rival Syngenta, Monsanto’s CEO, Hugh Grant, told journalists this week the company no longer sees “large scale” M&A as a viable strategy.

Instead, he said the company plans to look to research and development, and commercial partnerships to generate growth in its crop protectant and seeds business.

Presenting Monsanto’s quarterly results, Grant said he believes the agrochemicals industry will continue to rationalize, focusing investment to the higher-return options, and this will translate into further R&D or commercial partnerships” for which we are uniquely positioned to participate.”

While the Monsanto chief did not comment on any possible deals that might be in the works, the company has been seen as exploring potential collaborations with BASF and Bayer.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.